Restructuring lurks in pharmaceutical sector

Korea’s pharmaceutical sector is poised to head for a fresh round of restructuring, with many drug makers pushing employees to opt for early retirement plans amid growing worries over the lackluster earnings outlook due to the massive drug price cuts starting April.

The measure, designed to reduce insurance expenditures, left pharmaceutical companies taking the step to reduce their workforce...